ClinicalTrials.Veeva

Menu

Ask Questions (ASQ):Implementation of a Communication Intervention

B

Barbara Ann Karmanos Cancer Institute

Status

Completed

Conditions

Stage III Bladder Cancer
Stage III Kidney Cancer
Stage II Colorectal Cancer
Stage III Ovarian Cancer
Stage III Colorectal Cancer
Stage IV Kidney Cancer
Stage III Prostate Cancer
Stage III Lung Cancer
Stage II Ovarian Cancer
Stage II Prostate Cancer
Stage III Cervical Cancer
Stage II Kidney Cancer
Stage IV Prostate Cancer
Stage II Bladder Cancer
Stage IV Colorectal Cancer
Stage II Breast Cancer
Stage IV Bladder Cancer
Stage III Breast Cancer
Stage IV Ovarian Cancer
Stage II Lung Cancer
Stage IV Lung Cancer
Stage II Cervical Cancer
Stage IV Breast Cancer

Treatments

Behavioral: Behavioral Intervention

Study type

Interventional

Funder types

Other

Identifiers

NCT05025748
2021-025

Details and patient eligibility

About

This clinical trial implements a communication intervention to improve patient-oncologist communication in the outpatient medical oncology setting. A communication brochure called the ASQ brochure may help patients prepare for the doctor visit by thinking through the questions that patients and patients' family want to ask the doctor.

Full description

Patient-centered communication is critical to providing high-quality care. In patient-provider clinical interactions, providers are responsible for several aspects of patient-centered communication. However, to reach the goal of providing the best possible treatments, patients should also actively participate by asking questions and expressing their concerns. Question prompt lists, simple lists of questions provided to patients before clinic visits to help them prepare for the appointment, have been tested in several medical contexts and patient populations, including among an underserved, minority population in Detroit, and have been shown to contribute to improved outcomes related to better communication quality. Using a RE-AIM framework, this descriptive, mixed methods, single-arm intervention study assesses the implementation of an evidence-based communication intervention (question prompt list), the "ASQ brochure". The ASQ brochure is designed to improve patient-oncologist communication and other outcomes by improving patient self-efficacy for managing patient-physician interactions. Investigators will recruit 225 patients and implement the ASQ brochure at seven Karmanos Cancer Center network sites. Participants are newly diagnosed patients with (Stages I-IV) cancer for which systemic therapy is likely a recommended treatment.

Enrollment

81 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Adults 18 years of age or older
  • Have a first appointment to see a medical oncologist at a Karmanos Cancer Institute (KCC) site for medical/systemic treatment for a new, confirmed diagnosis of stages I-IV cancer
  • Speak and read English well enough to be able to understand consent documents
  • Given the diverse population seen at KCI, we will make attempts to recruit a representative sample. Our strategy will be simply to ask recruiters to make special attempts to recruit a representative sample. If that strategy fails after the first 10 patients we will build in requirements that at least 25% of the patients self-identify as non-White

Exclusion criteria

  • Not specified

Trial design

Primary purpose

Health Services Research

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

81 participants in 1 patient group

Health services research (ASQ brochure)
Experimental group
Description:
Patients receive ASQ brochure and complete questionnaires over 30 minutes at baseline, over 10 minutes pre-clinic visit, and over 30 minutes post-clinic visit.
Treatment:
Behavioral: Behavioral Intervention

Trial contacts and locations

8

Loading...

Central trial contact

Fatmeh Baidoun, MSW; Susan Eggly, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems